High burden of potentially avoidable stroke from discontinuation of warfarin therapy in non-valvular atrial fibrillation

被引：0
|
作者：
Freedman, S. B. [1 ,2 ]
Martinez, C. [3 ]
Wallenhorst, C. [3 ]
Katholing, A. [3 ]
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Concord Hosp, Anzac Inst, Dept Pathol Vasc Biol & Cardiol, Sydney, NSW, Australia
[3] Stat & Informat GmbH, Inst Epidemiol, Frankfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4981
引用
收藏
页码：862 / 862
页数：1
相关论文
共 50 条
  • [1] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
  • [2] WARFARIN DISCONTINUATION AND STROKE RISK AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A8 - A9
  • [3] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [4] Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients
    Lip, G. Y. H.
    Keshishian, A.
    Li, X.
    Lee, T. C.
    Mardekian, J.
    Posner, N.
    Luo, X.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 774 - 775
  • [5] Stroke prevention in non-valvular atrial fibrillation: Can warfarin do better?
    Apostolakis, Stavros
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) : 753 - 754
  • [6] Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
    Alberts, Mark J.
    Eikelboom, John W.
    Hankey, Graeme J.
    [J]. LANCET NEUROLOGY, 2012, 11 (12): : 1066 - 1081
  • [7] Warfarin utilization and stroke risk in patients with chronic non-valvular atrial fibrillation
    Boccuzzi, SJ
    Stephenson, JJ
    Kreilick, CA
    Beaulieu, JF
    Hauch, O
    Kim, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 335A - 335A
  • [8] Barriers to using warfarin in non-valvular atrial fibrillation
    Gattellari, M
    Zwar, NA
    Worthington, JM
    Middleton, S
    [J]. BRITISH MEDICAL JOURNAL, 2006, 332 (7536): : 303 - 304
  • [9] Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States
    Coleman, Craig I.
    Tangirala, Muralikrishna
    Evers, Thomas
    [J]. PLOS ONE, 2016, 11 (06):
  • [10] Non-valvular atrial fibrillation and stroke prevention
    Hankey, GJ
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (05) : 234 - 239
12345